22 pending office actions • 15 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19185311 | Untitled | Leaderna Therapeutics Ltd. | MCGARRY, SEAN | 1635 | Non-Final OA | |
| 18688377 | HALOGEN-SUBSTITUTED PYRIDAZINONE COMPOUND AND APPLICATION THEREOF | Medshine Discovery Inc. | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Mar 01, 2024 |
| 18684856 | CAMPTOTHECIN COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Best-Link Bioscience, LLC | DEKARSKE, MADELINE MCGUIRE | 1622 | Non-Final OA | Feb 20, 2024 |
| 18294559 | COMPOSITION, FORMULATION, PREPARATION METHOD AND USE FOR GLUTATHIONE PRECURSOR | Wuhan Grand Hoyo Co., Ltd. | PIHONAK, SARAH | 1627 | Non-Final OA | Feb 02, 2024 |
| 18580154 | NOVEL PARP7 INHIBITOR AND USE THEREOF | Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. | YOO, SUN JAE | 1621 | Non-Final OA | Jan 18, 2024 |
| 18570661 | POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION | Neushen Therapeutics (Shanghai) Co., Ltd. | JARRELL, NOBLE E | 1699 | Non-Final OA | Dec 15, 2023 |
| 18533232 | RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF | Fujian Akeylink Biotechnology Co., Ltd. | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Dec 08, 2023 |
| 18505192 | NAPHTHALENE RING-CONTAINING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | Asieris Pharmaceuticals (Shanghai) Co., Ltd. | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Nov 09, 2023 |
| 18550468 | 6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES | Medshine Discovery Inc. | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Sep 14, 2023 |
| 18549366 | BICYCLIC PHENOL COMPOUNDS AND USE THEREOF | Medshine Discovery Inc. | MOTEVALLI, OROD | 1628 | Non-Final OA | Sep 07, 2023 |
| 18264073 | AZAHETEROARYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shanghai Blueray Biopharma Co., Ltd. | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Aug 02, 2023 |
| 18263702 | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES | Medshine Discovery Inc. | HABTE, KAHSAY | 1624 | Non-Final OA | Jul 31, 2023 |
| 18262725 | CDK INHIBITOR | Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Jul 24, 2023 |
| 18253935 | NOVEL BENZAZEPINE SPIRO DERIVATIVE | Jiangxi Jemincare Group Co., Ltd. | ANDERSON, REBECCA L | 1626 | Non-Final OA | Jul 11, 2023 |
| 18005963 | BIONIC TISSUE STENT, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Sinobioprint (Shanghai) Biotech Ltd. | PELLEGRINO, BRIAN E | 3799 | Non-Final OA | Jan 18, 2023 |
| 17927139 | A LIVE STRAIN OF STAPHYLOCOCCUS AUREUS AND USES THEREOF | VERSITECH LIMITED | DICKENS, AMELIA NICOLE | 1645 | Final Rejection | Nov 22, 2022 |
| 17785501 | HEAVY RARE EARTH ALLOY, NEODYMIUM-IRON-BORON PERMANENT MAGNET MATERIAL RAW MATERIAL, AND PREPARATION METHOD | Fujian Golden Dragon Rare-Earth Co., Ltd. | POLLOCK, AUSTIN M | 1738 | Final Rejection | Jun 15, 2022 |
| 17785041 | NEODYMIUM-IRON-BORON MAGNET MATERIAL, RAW MATERIAL COMPOSITION PREPARATION METHOD THEREFOR AND USE THEREOF | Fujian Golden Dragon Rare-Earth Co., Ltd. | O'KEEFE, SEAN P | 1738 | Final Rejection | Jun 13, 2022 |
| 17784996 | R-T-B-BASED SINTERED MAGNET AND PREPARATION METHOD THEREFOR | Fujian Golden Dragon Rare-Earth Co., Ltd. | SHAMS, NAZMUN NAHAR | 1738 | Non-Final OA | Jun 13, 2022 |
| 17635156 | R-T-B SERIES PERMANENT MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD AND APPLICATION | Fujian Golden Dragon Rare-Earth Co., Ltd. | WANG, NICHOLAS A | 1734 | Final Rejection | Feb 14, 2022 |
| 17600105 | NEODYMIUM-IRON-BORON MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Fujian Golden Dragon Rare-Earth Co., Ltd. | SU, XIAOWEI | 1733 | Final Rejection | Sep 30, 2021 |
| 17600107 | RTB-Based Permanent Magnet Material, Preparation Method thereof, and Application thereof | Fujian Golden Dragon Rare-Earth Co., Ltd. | HILL, STEPHANI A | 1735 | Final Rejection | Sep 30, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial